Abstract
Chikungunya virus (CHIKV) is the etiological agent of the Chikungunya fever which has spread worldwide. Clinically, this disease may lead to prolonged incapacitating joint pain that can compromise remarkably the patients’ quality of life. However, there are no licensed vaccines or specific drugs to fight this infection yet, making the search for novel therapies an imperative need. In this scenario, the CHIKV nsP2 protease emerged as an attractive therapeutic target once this protein plays a pivotal role in viral replication and pathogenesis. Hence, we investigated the structural basis for the inhibition of this enzyme by using molecular docking and dynamics simulations. Compounds with inhibitory activities against CHIKV nsP2 protease determined experimentally were selected from the literature. Docking studies with a set of stereoisomers showed that trans isomers, but not cis ones, bound close to the catalytic dyad which may explain isomerism requirements to the enzyme’s inhibition. Further, binding mode analyses of other known inhibitors revealed highly conserved contacts between inhibitors and enzyme residues like N1011, C1013, A1046, Y1079, N1082, W1084, L1205, and M1242. Molecular dynamics simulations reinforced the importance of some of these interactions and pointed to nonpolar interactions as the main forces for inhibitors’ binding. Finally, we observed that true inhibitors exhibited lower structural fluctuation, higher ligand efficiency and did not induce significant changes in protein correlated motions. Collectively, our findings might allow discerning true inhibitors from false ones and can guide drug development efforts targeting the nsP2 protease to fight CHIKV infections in the future.
Similar content being viewed by others
Data availability
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
Code availability
Not applicable.
References
de Ximenes MdeFFM, de Galvão JMA, Inacio CLS et al (2020) Arbovirus expansion: new species of culicids infected by the Chikungunya virus in an urban park of Brazil. Acta Trop 209:1–5. https://doi.org/10.1016/J.ACTATROPICA.2020.105538
Abdelnabi R, Neyts J, Delang L (2017) Chikungunya virus infections: time to act, time to treat. Curr Opin Virol 24:25–30. https://doi.org/10.1016/j.coviro.2017.03.016
Vairo F, Haider N, Kock R et al (2019) Chikungunya: epidemiology, pathogenesis, clinical features, management, and prevention. Infect Dis Clin North Am 33:1003–1025. https://doi.org/10.1016/j.idc.2019.08.006
ECDC (2022) Chikungunya worldwide overview. https://www.ecdc.europa.eu/en/chikungunya-monthly.
Kraemer MUG, Reiner RC, Brady OJ et al (2019) Past and future spread of the arbovirus vectors Aedes aegypti and Aedes albopictus. Nat Microbiol 4:854–863. https://doi.org/10.1038/s41564-019-0376-y
Natrajan MS, Rojas A, Waggoner JJ (2019) Beyond fever and pain: diagnostic methods for chikungunya virus. J Clin Microbiol 57:1–14. https://doi.org/10.1128/JCM.00350-19
Mehta R, Gerardin P, de Brito CAA et al (2018) The neurological complications of chikungunya virus: a systematic review. Rev Med Virol 28:1–24. https://doi.org/10.1002/rmv.1978
Thiberville S-D, Moyen N, Dupuis-Maguiraga L et al (2013) Chikungunya fever: epidemiology, clinical syndrome, pathogenesis and therapy. Antiviral Res 99:345–370. https://doi.org/10.1016/j.antiviral.2013.06.009
Thompson R, Del CJM, Constenla D (2020) A review of the economic evidence of Aedes-borne arboviruses and Aedes-borne arboviral disease prevention and control strategies. Expert Rev Vaccines 19:143–162. https://doi.org/10.1080/14760584.2020.1733419
Cardona-Ospina JA, Villamil-Gómez WE, Jimenez-Canizales CE et al (2015) Estimating the burden of disease and the economic cost attributable to chikungunya, Colombia, 2014. Trans R Soc Trop Med Hyg 109:793–802. https://doi.org/10.1093/trstmh/trv094
Feldstein LR, Ellis EM, Rowhani-Rahbar A et al (2019) Estimating the cost of illness and burden of disease associated with the 2014–2015 chikungunya outbreak in the U.S. Virgin Islands PLoS Negl Trop Dis 13:1–14. https://doi.org/10.1371/journal.pntd.0007563
van Aalst M, Nelen CM, Goorhuis A et al (2017) Long-term sequelae of chikungunya virus disease: a systematic review. Travel Med Infect Dis 15:8–22. https://doi.org/10.1016/J.TMAID.2017.01.004
Subudhi BB, Chattopadhyay S, Mishra P, Kumar A (2018) Current strategies for inhibition of Chikungunya infection. Viruses 10:1–40. https://doi.org/10.3390/v10050235
Ganesan V, Duan B, Reid S (2017) Chikungunya virus: pathophysiology, mechanism, and modeling. Viruses 9:1–14. https://doi.org/10.3390/v9120368
Rupp JC, Sokoloski KJ, Gebhart NN, Hardy RW (2015) Alphavirus RNA synthesis and non-structural protein functions. J Gen Virol 96:2483–2500. https://doi.org/10.1099/jgv.0.000249
Shin G, Yost SA, Miller MT et al (2012) Structural and functional insights into alphavirus polyprotein processing and pathogenesis. Proc Natl Acad Sci 109:16534–16539. https://doi.org/10.1073/pnas.1210418109
Saisawang C, Saitornuang S, Sillapee P et al (2015) Chikungunya nsP2 protease is not a papain-like cysteine protease and the catalytic dyad cysteine is interchangeable with a proximal serine. Sci Rep 5:17125. https://doi.org/10.1038/srep17125
Fros JJ, van der Maten E, Vlak JM, Pijlman GP (2013) The C-terminal domain of chikungunya virus nsP2 independently governs viral RNA replication, cytopathicity, and inhibition of interferon signaling. J Virol 87:10394–10400. https://doi.org/10.1128/JVI.00884-13
Narwal M, Singh H, Pratap S et al (2018) Crystal structure of chikungunya virus nsP2 cysteine protease reveals a putative flexible loop blocking its active site. Int J Biol Macromol 116:451–462. https://doi.org/10.1016/j.ijbiomac.2018.05.007
Rabelo VW, Paixão ICNP, Abreu PA (2020) Targeting Chikungunya virus by computational approaches: from viral biology to the development of therapeutic strategies. Expert Opin Ther Targets 24:63–78. https://doi.org/10.1080/14728222.2020.1712362
Hu X, Compton JR, Leary DH et al (2016) Kinetic, mutational, and structural studies of the Venezuelan equine encephalitis virus nonstructural protein 2 cysteine protease. Biochemistry 55:3007–3019. https://doi.org/10.1021/acs.biochem.5b00992
Jones G, Willett P, Glen RC et al (1997) Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E Cohen J Mol Biol 267:727–748. https://doi.org/10.1006/jmbi.1996.0897
Trott O, Olson AJ (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31:455–461. https://doi.org/10.1002/jcc.21334
Koes DR, Baumgartner MP, Camacho CJ (2013) Lessons learned in empirical scoring with smina from the CSAR 2011 Benchmarking Exercise. J Chem Inf Model 53:1893–1904. https://doi.org/10.1021/ci300604z
Bassetto M, De Burghgraeve T, Delang L et al (2013) Computer-aided identification, design and synthesis of a novel series of compounds with selective antiviral activity against chikungunya virus. Antiviral Res 98:12–18. https://doi.org/10.1016/j.antiviral.2013.01.002
Das PK, Puusepp L, Varghese FS et al (2016) Design and validation of novel chikungunya virus protease inhibitors. Antimicrob Agents Chemother 60:7382–7395. https://doi.org/10.1128/AAC.01421-16
Dolinsky TJ, Nielsen JE, McCammon JA, Baker NA (2004) PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations. Nucleic Acids Res 32:W665–W667. https://doi.org/10.1093/nar/gkh381
Guex N, Peitsch MC, Schwede T (2009) Automated comparative protein structure modeling with SWISS-MODEL and Swiss-PdbViewer: a historical perspective. Electrophoresis 30:162–173. https://doi.org/10.1002/elps.200900140
Guex N, Peitsch MC (1997) SWISS-MODEL and the Swiss-Pdb Viewer: an environment for comparative protein modeling. Electrophoresis 18:2714–2723. https://doi.org/10.1002/elps.1150181505
Case DA, Cerutti DS, Cheatham TE, et al (2017) AMBER 2017
Jorgensen WL, Chandrasekhar J, Madura JD et al (1983) Comparison of simple potential functions for simulating liquid water. J Chem Phys 79:926. https://doi.org/10.1063/1.445869
Pettersen EF, Goddard TD, Huang CC et al (2004) UCSF Chimera - a visualization system for exploratory research and analysis. J Comput Chem 25:1605–1612. https://doi.org/10.1002/jcc.20084
Jakalian A, Jack DB, Bayly CI (2002) Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II Parameterization and validation. J Comput Chem 23:1623–1641. https://doi.org/10.1002/jcc.10128
Ryckaert JP, Ciccotti G, Berendsen HJC (1977) Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J Comput Phys 23:327–341. https://doi.org/10.1016/0021-9991(77)90098-5
Darden T, York D, Pedersen L (1993) Particle mesh Ewald: an N⋅log(N) method for Ewald sums in large systems. J Chem Phys 98:10089–10092. https://doi.org/10.1063/1.464397
Humphrey W, Dalke A, Schulten K (1996) VMD: visual molecular dynamics. J Mol Graph 14(33–8):27–28
Hou T, Wang J, Li Y, Wang W (2011) Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations. J Chem Inf Model 51:69–82. https://doi.org/10.1021/ci100275a
Ramírez D, Caballero J (2016) Is it reliable to use common molecular docking methods for comparing the binding affinities of enantiomer pairs for their protein target? Int J Mol Sci 17:1–15. https://doi.org/10.3390/ijms17040525
Russo AT, Malmstrom RD, White MA, Watowich SJ (2010) Structural basis for substrate specificity of alphavirus nsP2 proteases. J Mol Graph Model 29:46–53. https://doi.org/10.1016/j.jmgm.2010.04.005
Rausalu K, Utt A, Quirin T et al (2016) Chikungunya virus infectivity, RNA replication and non-structural polyprotein processing depend on the nsP2 protease’s active site cysteine residue. Sci Rep 6:37124. https://doi.org/10.1038/srep37124
Nguyen PTV, Yu H, Keller PA (2015) Identification of chikungunya virus nsP2 protease inhibitors using structure-base approaches. J Mol Graph Model 57:1–8. https://doi.org/10.1016/j.jmgm.2015.01.001
Ramakrishnan C, Kutumbarao NHVV, Suhitha S, Velmurugan D (2017) Structure–function relationship of Chikungunya nsP2 protease: a comparative study with papain. Chem Biol Drug Des 89:772–782. https://doi.org/10.1111/cbdd.12901
Aggarwal M, Sharma R, Kumar P et al (2015) Kinetic characterization of trans-proteolytic activity of Chikungunya virus capsid protease and development of a FRET-based HTS assay. Sci Rep 5:1–12. https://doi.org/10.1038/srep14753
Dhindwal S, Kesari P, Singh H et al (2017) Conformer and pharmacophore based identification of peptidomimetic inhibitors of Chikungunya virus NSP2 protease. J Biomol Struct Dyn 35:3522–3539. https://doi.org/10.1080/07391102.2016.1261046
El-labbad EM, Ismail MAHH, Abou Ei Ella DA et al (2015) Discovery of novel peptidomimetics as irreversible CHIKV NsP2 protease inhibitors using quantum mechanical-based ligand descriptors. Chem Biol Drug Des 86:1518–1527. https://doi.org/10.1111/cbdd.12621
Giancotti G, Cancellieri M, Balboni A et al (2018) Rational modifications on a benzylidene-acrylohydrazide antiviral scaffold, synthesis and evaluation of bioactivity against Chikungunya virus. Eur J Med Chem 149:56–68. https://doi.org/10.1016/j.ejmech.2018.02.054
Tardugno R, Giancotti G, De Burghgraeve T et al (2018) Design, synthesis and evaluation against Chikungunya virus of novel small-molecule antiviral agents. Bioorganic Med Chem 26:869–874. https://doi.org/10.1016/j.bmc.2018.01.002
Jadav SS, Sinha BN, Hilgenfeld R et al (2014) Thiazolidone derivatives as inhibitors of chikungunya virus. Eur J Med Chem 89:172–178. https://doi.org/10.1016/j.ejmech.2014.10.042
Mishra P, Kumar A, Mamidi P et al (2016) Inhibition of chikungunya virus replication by 1-[(2-methylbenzimidazol-1-yl) methyl]-2-oxo-indolin-3-ylidene] amino] thiourea(MBZM-N-IBT). Sci Rep 6:1–13. https://doi.org/10.1038/srep20122
Kumar P, Kumar D, Giri R (2019) Targeting the nsp2 cysteine protease of Chikungunya virus using FDA approved library and selected Cysteine protease inhibitors. Pathogens 8:128. https://doi.org/10.3390/pathogens8030128
Ivanova L, Rausalu K, Žusinaite E et al (2021) 1,3-Thiazolbenzamide derivatives as chikungunya virus nsP2 protease inhibitors. ACS Omega 6:5786–5794. https://doi.org/10.1021/ACSOMEGA.0C06191
Tripathi PK, Soni A, Singh Yadav SP et al (2020) Evaluation of novobiocin and telmisartan for anti-CHIKV activity. Virology 548:250–260. https://doi.org/10.1016/j.virol.2020.05.010
Eberle RJ, Olivier DS, Pacca CC et al (2021) In vitro study of Hesperetin and Hesperidin as inhibitors of zika and chikungunya virus proteases. PLoS One 16:e0246319. https://doi.org/10.1371/JOURNAL.PONE.0246319
Nam S, Ga YJ, Lee JY et al (2021) Radicicol inhibits Chikungunya virus replication by targeting nonstructural protein 2. Antimicrob Agents Chemother 65:e0013521. https://doi.org/10.1128/AAC.00135-21
Singh H, Mudgal R, Narwal M et al (2018) Chikungunya virus inhibition by peptidomimetic inhibitors targeting virus-specific cysteine protease. Biochimie 149:51–61. https://doi.org/10.1016/j.biochi.2018.04.004
Acknowledgements
We thank the Laboratório Nacional de Computação Científica, CENAPAD, RJ, for providing high-performance computing resources. Also, we thank Dr. Helena Carla Castro from Universidade Federal Fluminense for supplying computational resources used to execute part of this work.
Funding
This study was financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior – Brasil (CAPES) – Finance Code 001. In addition, this work was supported by the Brazilian agencies National Council for Scientific and Technological Development (CNPQ) and Research Support Foundation of the State of Rio de Janeiro (FAPERJ).
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by Vitor Won-Held Rabelo. The first draft of the manuscript was written by Vitor Won-Held Rabelo and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Rabelo, V.WH., de Palmer Paixão, I.C.N. & Abreu, P.A. Structural insights into the inhibition of the nsP2 protease from Chikungunya virus by molecular modeling approaches. J Mol Model 28, 311 (2022). https://doi.org/10.1007/s00894-022-05316-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00894-022-05316-3